MedTrace Logo

Radial Access for Abdominopelvic Vascular Intervention

NCT05956860 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1143

Last updated 2023-12-21

No results posted yet for this study

Summary

To evaluate the safety and efficacy of R.A.V.I.(radial access for abdominopelvic vascular intervention), and evaluate the feasibility and safety of repeated radial artery intervention

Conditions

  • Vascular Access Device Complications

Interventions

PROCEDURE

abdominopelvic vascular intervention through the radial artery access

According to the pathological changes and needs of the subjects (any abdominal and pelvic arterial intervention that can be performed through the radial artery access, including but not limited to: 1. hepatic intervention, such as transarterial chemoembolization (TACE), hepatic arterial infusion chemotherapy (HAIC), etc.; 2. Other visceral intervention, such as spleen, kidney, mesentery, etc.; 3. Pelvic intervention, such as uterine artery embolism, prostatic artery embolism, etc.; 4. Others, such as preoperative embolization of bone tumors (lumbar, sacral vertebra), etc.

Sponsors & Collaborators

  • Terumo Medical Corporation

    collaborator INDUSTRY

  • Zhongda Hospital

    lead OTHER

Principal Investigators

  • Gao-Jun Teng, MD · Zhongda Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-07
Primary Completion
2024-12-30
Completion
2025-12-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05956860 on ClinicalTrials.gov